Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The efficacy of oral corticosteroids for the treatment of relapses of multiple sclerosis has
not been proved. French neurologists treat such patients with intravenous corticosteroids.
The aim of the study is to check if the efficacy of high dose oral methylprednisolone is
similar to the efficacy intravenous (IV) prednisolone. The main criteria of efficacy is
symptom recovery within 28 days after inclusion.